Skip to content

uniQure N.V.

QURE

CIK 0001590560 · Pharmaceutical Preparations · Nasdaq

  • uniQure B.V. (until 2014-02-06)
← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$215.42M
+16.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.74
+29.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$226.17M
Q1 May 2026
Cash
$139.99M
Q1 May 2026
Total Debt
$61.05M
Q1 May 2026
Shares Outstanding
63.07M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings